Erratum to: Management Strategies for Clopidogrel Hypersensitivity.
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 913, doi. 10.1007/s40265-016-0580-5
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2016 AND VI 76 AND IP 8
Results: 9
1
2
Ixekizumab: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 901, doi. 10.1007/s40265-016-0579-y
- By:
- Publication type:
- Article
3
Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia.
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 869, doi. 10.1007/s40265-016-0581-4
- By:
- Publication type:
- Article
4
Reslizumab: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 907, doi. 10.1007/s40265-016-0583-2
- By:
- Publication type:
- Article
5
Gabapentin Enacarbil: A Review in Restless Legs Syndrome.
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 879, doi. 10.1007/s40265-016-0584-1
- By:
- Publication type:
- Article
6
Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 841, doi. 10.1007/s40265-016-0575-2
- By:
- Publication type:
- Article
7
Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 831, doi. 10.1007/s40265-016-0578-z
- By:
- Publication type:
- Article
8
Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 889, doi. 10.1007/s40265-016-0585-0
- By:
- Publication type:
- Article
9
Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 853, doi. 10.1007/s40265-016-0573-4
- By:
- Publication type:
- Article